Gastrointestinal Cancer News

Total neoadjuvant therapy prior to chemoradiotherapy facilitated delivery of systemic therapy and improved treatment response among patients with locally advanced rectal cancer, according to results of a retrospective cohort analysis.

Talimogene laherparevec, a genetically modified version of the herpes virus, was well-tolerated after injection into active cancer in the liver and stimulated patient immune systems to destroy cancer cells throughout the body, according to a press release and presentation at the Society of Interventional Radiology Annual Scientific Meeting.

Surfactant-shelled oxygen microbubbles injected via IV may improve response to radiation therapy, according to study results.

Men and women with high BMI and hepatitis B virus infection are at increased risk for hepatocellular carcinoma, according to study findings.

While rates of death from gallbladder and other biliary tract cancers are declining in most countries worldwide, several high-income nations are experiencing an increase after years of lower rates, according to research published in Clinical Gastroenterology and Hepatology.

Patients with early gastric cancer who received treatment for Helicobacter pylori infection had a 50% lower incidence of metachronous gastric cancer, according to results of a single-center, double-blind prospective randomized clinical trial.

An encapsulated balloon device combined with methylated DNA biomarkers demonstrated sensitivity and specificity higher than 90% for the detection of Barrett’s esophagus, a precursor to esophageal cancer.

Researchers have developed a predictive score that quantifies the potential benefits of direct-acting antiviral therapy for patients with hepatitis C and decompensated cirrhosis, according to recently published data.

Patients with increased visceral adipose tissue are more likely to develop precancerous colorectal adenomas, according to research published in Gastrointestinal Endoscopy.

A report published in Annals of Oncology projects that colorectal cancer death rates in Europe may drop by as much as 7% in 2018 compared with rates in 2012.